Aureus Asset Management’s Eli Lilly LLY Stock Holding History

Aureus Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.69M	Buy	4,008 +542	+16%	+$549K	0.25%	52
2025 Q4	$3.72M	Sell	3,466 -94	-3%	-$89.9K	0.24%	57
2025 Q3	$2.72M	Hold	3,560	–	–	0.18%	62
2025 Q2	$2.78M	Buy	3,560 +83	+2%	+$64.5K	0.18%	65
2025 Q1	$2.87M	Buy	3,477 +48	+1%	+$39.9K	0.2%	65
2024 Q4	$2.65M	Sell	3,429 -2	-0.1%	-$1.66K	0.17%	66
2024 Q3	$3.04M	Buy	3,431 +2	+0.1%	+$1.8K	0.2%	63
2024 Q2	$3.1M	Sell	3,429 -248	-7%	-$198K	0.22%	64
2024 Q1	$2.86M	Buy	3,677 +23	+0.6%	+$16.4K	0.2%	65
2023 Q4	$2.13M	Hold	3,654	–	–	0.16%	70
2023 Q3	$1.96M	Buy	3,654 +105	+3%	+$54.1K	0.16%	70
2023 Q2	$1.66M	Hold	3,549	–	–	0.12%	76
2023 Q1	$1.22M	Buy	3,549 +173	+5%	+$58.3K	0.1%	82
2022 Q4	$1.24M	Sell	3,376 -840	-20%	-$298K	0.11%	84
2022 Q3	$1.36M	Buy	4,216 +227	+6%	+$71.9K	0.12%	75
2022 Q2	$1.29M	Hold	3,989	–	–	0.1%	82
2022 Q1	$1.14M	Buy	+3,989	New	+$1.03M	0.08%	98

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aureus Asset Management's LLY Position: Q1 2026 in Review

Aureus Asset Management increased its Eli Lilly (LLY) stake by 16% in Q1 2026, buying an estimated $549K and bringing the position to 4,008 shares worth $3.69M. The position accounts for 0.25% of the portfolio, ranked #52.

Aureus Asset Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.72M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Aureus Asset Management held 4,008 shares of Eli Lilly worth $3.69M as of Q1 2026.
Aureus Asset Management bought 542 Eli Lilly shares in Q1 2026, an estimated $549K.
Eli Lilly made up 0.25% of Aureus Asset Management's portfolio in Q1 2026, its #52 holding.
Aureus Asset Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
Aureus Asset Management's Eli Lilly position peaked at $3.72M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.